{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:04:50Z","timestamp":1781111090653,"version":"3.54.1"},"reference-count":72,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>In the current era, the survival of extremely low-birth-weight infants has increased considerably because of new advances in technology; however, these infants often develop chronic dysfunction of the lung, which is called bronchopulmonary dysplasia (BPD). BPD remains an important cause of neonatal mortality and morbidity despite newer and gentler modes of ventilation. BPD results from the exposure of immature lungs to various antenatal and postnatal factors that lead to an impairment in lung development and aberrant growth of lung parenchyma and vasculature. However, we still struggle with a uniform definition for BPD that can help predict various short- and long-term pulmonary outcomes. With new research, our understanding of the pathobiology of this disease has evolved, and many new mechanisms of lung injury and repair are now known. By utilizing the novel \u2018omic\u2019 approaches in BPD, we have now identified various factors in the disease process that may act as novel therapeutic targets in the future. New investigational agents being explored for the management and prevention of BPD include mesenchymal stem cell therapy and insulin-like growth factor 1. Despite this, many questions remain unanswered and require further research to improve the outcomes of premature infants with BPD.<\/ns4:p>","DOI":"10.12688\/f1000research.25338.1","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:15:11Z","timestamp":1594721711000},"page":"703","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Recent advances in understanding and management of bronchopulmonary dysplasia"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-2073","authenticated-orcid":false,"given":"Mitali","family":"Sahni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-6636","authenticated-orcid":false,"given":"Vineet","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"357-68","DOI":"10.1056\/NEJM196702162760701","article-title":"Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.","volume":"276","author":"W Northway","year":"1967","journal-title":"N Engl J Med."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"444-52","DOI":"10.1053\/j.semperi.2018.09.006","article-title":"Surfactant, steroids and non-invasive ventilation in the prevention of BPD.","volume":"42","author":"V Dumpa","year":"2018","journal-title":"Semin Perinatol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.12688\/f1000research.10832.1","article-title":"How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and \u201ctomorrow\u201d [version 1; peer review: 2 approved].","volume":"6","author":"L Nelin","year":"2017","journal-title":"F1000Res."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"384-91","DOI":"10.1159\/000497422","article-title":"Bronchopulmonary Dysplasia: 50 Years after the Original Description.","volume":"115","author":"E Bancalari","year":"2019","journal-title":"Neonatology."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1562-73","DOI":"10.1542\/peds.2008-1962","article-title":"Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia.","volume":"123","author":"A Bhandari","year":"2009","journal-title":"Pediatrics."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1039-51","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.","volume":"314","author":"B Stoll","year":"2015","journal-title":"JAMA."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia.","volume":"5","author":"B Th\u00e9baud","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"999-1014","DOI":"10.1016\/j.ajpath.2019.01.014","article-title":"Genetic Strain and Sex Differences in a Hyperoxia-Induced Mouse Model of Varying Severity of Bronchopulmonary Dysplasia.","volume":"189","author":"S Leary","year":"2019","journal-title":"Am J Pathol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"e450-8","DOI":"10.1542\/peds.2008-3249","article-title":"Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.","volume":"124","author":"C Bose","year":"2009","journal-title":"Pediatrics."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"F8-F17","DOI":"10.1136\/adc.2010.210187","article-title":"Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: A systematic review and meta-analysis.","volume":"97","author":"L Hartling","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"272-7","DOI":"10.1515\/JPM.2004.051","article-title":"Intrauterine smoke exposure: A new risk factor for bronchopulmonary dysplasia?","volume":"32","author":"R Antonucci","year":"2004","journal-title":"J Perinat Med."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"170-7","DOI":"10.1016\/j.rmed.2017.10.014","article-title":"Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.","volume":"132","author":"R Kalikkot Thekkeveedu","year":"2017","journal-title":"Respir Med."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"e20152163","DOI":"10.1542\/peds.2015-2163","article-title":"Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort Study.","volume":"137","author":"H Torchin","year":"2016","journal-title":"Pediatrics."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"101-7","DOI":"10.2350\/15-05-1646-OA.1","article-title":"Placental Villous Vascularity is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.","volume":"19","author":"S Yallapragada","year":"2016","journal-title":"Pediatr Dev Pathol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"809-10","DOI":"10.1038\/s41390-020-0819-4","article-title":"Is bronchopulmonary dysplasia decided before birth?","volume":"87","author":"V Bhandari","year":"2020","journal-title":"Pediatr Res."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"364-74","DOI":"10.1164\/rccm.201612-2414OC","article-title":"Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.","volume":"196","author":"L Morrow","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"413-24","DOI":"10.1053\/j.semperi.2018.09.002","article-title":"Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.","volume":"42","author":"E Taglauer","year":"2018","journal-title":"Semin Perinatol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"e0170120","DOI":"10.1371\/journal.pone.0170120","article-title":"Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants.","volume":"12","author":"B Wagner","year":"2017","journal-title":"PLoS One."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"126-133.e2","DOI":"10.1016\/j.jpeds.2018.08.042","article-title":"Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.","volume":"204","author":"M Pammi","year":"2019","journal-title":"J Pediatr."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"31023","DOI":"10.1038\/srep31023","article-title":"The Airway Microbiome at Birth.","volume":"6","author":"C Lal","year":"2016","journal-title":"Sci Rep."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"L1101-L1153","DOI":"10.1152\/ajplung.00343.2017","article-title":"Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.","volume":"313","author":"D Surate Solaligue","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"586-8","DOI":"10.1038\/s41390-018-0167-9","article-title":"The definition of bronchopulmonary dysplasia: An evolving dilemma.","volume":"84","author":"J Ibrahim","year":"2018","journal-title":"Pediatr Res."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"1723-9","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia.","volume":"163","author":"A Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"19-23","DOI":"10.1016\/j.jpeds.2017.06.064","article-title":"Can We Define Bronchopulmonary Dysplasia?","volume":"188","author":"A Jobe","year":"2017","journal-title":"J Pediatr."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"300-8","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary Dysplasia: Executive Summary of a Workshop.","volume":"197","author":"R Higgins","year":"2018","journal-title":"J Pediatr."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"8-10","DOI":"10.1016\/j.jpeds.2018.02.047","article-title":"Bronchopulmonary Dysplasia: The Ongoing Search for One Definition to Rule Them All.","volume":"197","author":"E Jensen","year":"2018","journal-title":"J Pediatr."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"751-9","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.","volume":"200","author":"E Jensen","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"537-40","DOI":"10.1055\/s-0038-1637761","article-title":"Bronchopulmonary Dysplasia: Can We Agree on a Definition?","volume":"35","author":"E Bancalari","year":"2018","journal-title":"Am J Perinatol."},{"key":"ref-29","article-title":"Bronchopulmonary Dysplasia. StatPearls","author":"M Sahni","year":"2019"},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"173-9","DOI":"10.1016\/j.prrv.2013.02.008","article-title":"Biomarkers in bronchopulmonary dysplasia.","volume":"14","author":"A Bhandari","year":"2013","journal-title":"Paediatr Respir Rev."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"184-7","DOI":"10.1136\/thoraxjnl-2018-212384","article-title":"Altered relaxation times in MRI indicate bronchopulmonary dysplasia.","volume":"75","author":"K F\u00f6rster","year":"2020","journal-title":"Thorax."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"109-14","DOI":"10.1016\/j.cca.2019.09.025","article-title":"Metabolomics of bronchopulmonary dysplasia.","volume":"500","author":"F Piersigilli","year":"2020","journal-title":"Clinica Chimica Acta."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"L870-L881","DOI":"10.1152\/ajplung.00283.2017","article-title":"Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.","volume":"315","author":"M La Frano","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11306-019-1482-9","article-title":"Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.","volume":"15","author":"F Piersigilli","year":"2019","journal-title":"Metabolomics."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"L810-L815","DOI":"10.1152\/ajplung.00085.2018","article-title":"Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.","volume":"315","author":"C Lal","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"1758-64","DOI":"10.3109\/14767058.2015.1061495","article-title":"Biomarkers in neonatology: The new \u201comics\u201d of bronchopulmonary dysplasia.","volume":"29","author":"F Piersigilli","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"401-12","DOI":"10.1016\/j.jprot.2013.10.007","article-title":"Calcium signaling-related proteins are associated with broncho-pulmonary dysplasia progression.","volume":"94","author":"C Magagnotti","year":"2013","journal-title":"J Proteomics."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-019-0676-0","article-title":"Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia.","volume":"45","author":"M Zasada","year":"2019","journal-title":"Ital J Pediatr."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"1076-80","DOI":"10.1164\/rccm.201706-1218LE","article-title":"Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening.","volume":"197","author":"K F\u00f6rster","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"S20-S27","DOI":"10.1038\/jp.2016.45","article-title":"Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants.","volume":"36 Suppl 2","author":"N Ambalavanan","year":"2016","journal-title":"J Perinatol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"e78585","DOI":"10.1371\/journal.pone.0078585","article-title":"Gene expression profiling in preterm infants: New aspects of bronchopulmonary dysplasia development.","volume":"8","author":"J Pietrzyk","year":"2013","journal-title":"PLoS One."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"531-537.e13","DOI":"10.1016\/j.jpeds.2014.09.052","article-title":"Integrated Genomic Analyses in Bronchopulmonary Dysplasia.","volume":"166","author":"N Ambalavanan","year":"2015","journal-title":"J Pediatr."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"425-31","DOI":"10.1053\/j.semperi.2018.09.004","article-title":"Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia.","volume":"42","author":"C Lal","year":"2018","journal-title":"Semin Perinatol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41467-017-01349-y","article-title":"Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs.","volume":"8","author":"M Syed","year":"2017","journal-title":"Nat Commun."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"34-6","DOI":"10.15698\/cst2018.02.124","article-title":"miR34a: A master regulator in the pathogenesis of bronchopulmonary dysplasia.","volume":"2","author":"P Das","year":"2018","journal-title":"Cell Stress."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12931-020-01353-9","article-title":"Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia.","volume":"21","author":"M Gilfillan","year":"2020","journal-title":"Respir Res."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"L981-L984","DOI":"10.1152\/ajplung.00390.2016","article-title":"Of mice and men: Correlations between microRNA-17\u223c92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia.","volume":"311","author":"M Robbins","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"L339-L349","DOI":"10.1152\/ajplung.00273.2016","article-title":"miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.","volume":"313","author":"S Durrani-Kolarik","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"e93994","DOI":"10.1172\/jci.insight.93994","article-title":"Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.","volume":"3","author":"C Lal","year":"2018","journal-title":"JCI Insight."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"579-88","DOI":"10.1038\/s41390-019-0524-3","article-title":"Hyperoxia causes miR199a-5p-mediated injury in the developing lung.","volume":"86","author":"M Alam","year":"2019","journal-title":"Pediatr Res."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"L476-87","DOI":"10.1152\/ajplung.00145.2015","article-title":"Regulation of alveolar septation by microRNA-489.","volume":"310","author":"N Olave","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"1962-8","DOI":"10.1056\/NEJM199906243402505","article-title":"Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants. National Institute of Child Health and Human Development Neonatal Research Network.","volume":"340","author":"J Tyson","year":"1999","journal-title":"N Engl J Med."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"771-80","DOI":"10.1055\/s-0032-1333410","article-title":"Vitamin A supplementation in extremely low-birth-weight infants: Subgroup analysis in small-for-gestational-age infants.","volume":"30","author":"V Londhe","year":"2013","journal-title":"Am J Perinatol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"273-91","DOI":"10.1016\/j.clp.2018.01.012","article-title":"Optimizing Caffeine Use and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review, Meta-analysis, and Application of Grading of Recommendations Assessment, Development, and Evaluation Methodology.","volume":"45","author":"M Pakvasa","year":"2018","journal-title":"Clin Perinatol."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"202-6","DOI":"10.1016\/j.siny.2019.04.007","article-title":"Prophylactic postnatal corticosteroids: Early hydrocortisone.","volume":"24","author":"O Baud","year":"2019","journal-title":"Semin Fetal Neonatal Med."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"2074-82","DOI":"10.1001\/jama.2014.5217","article-title":"Vitamin C Supplementation for Pregnant Smoking Women and Pulmonary Function in Their Newborn Infants: A Randomized Clinical Trial.","volume":"311","author":"C McEvoy","year":"2014","journal-title":"JAMA."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1139-47","DOI":"10.1164\/rccm.201805-1011OC","article-title":"Oral Vitamin C (500 mg\/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial.","volume":"199","author":"C McEvoy","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"673-9","DOI":"10.1542\/peds.2008-2793","article-title":"Time-Related Changes in Steroid Use and Bronchopulmonary Dysplasia in Preterm Infants.","volume":"124","author":"B Yoder","year":"2009","journal-title":"Pediatrics."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"790-8","DOI":"10.1038\/sj.mp.4001679","article-title":"Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation.","volume":"10","author":"C Crochemore","year":"2005","journal-title":"Mol Psychiatry."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"136-142.e5","DOI":"10.1016\/j.jpeds.2018.10.004","article-title":"Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis.","volume":"207","author":"M Shaffer","year":"2019","journal-title":"J Pediatr."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"e1310-8","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: A pilot study.","volume":"121","author":"T Yeh","year":"2008","journal-title":"Pediatrics."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"86-95","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal Administration of Budesonide\/Surfactant to Prevent Bronchopulmonary Dysplasia.","volume":"193","author":"T Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"378-83","DOI":"10.1097\/MOP.0000000000000613","article-title":"Novel therapeutics for bronchopulmonary dysplasia.","volume":"30","author":"L Strueby","year":"2018","journal-title":"Curr Opin Pediatr."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"158-68","DOI":"10.1002\/sctm.19-0193","article-title":"Are all stem cells equal? Systematic review, evidence map and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.","volume":"9","author":"S Augustine","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"104-16","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.","volume":"197","author":"G Willis","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-018-0903-4","article-title":"Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.","volume":"9","author":"S Chaubey","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"966-972.e6","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: Phase 1 dose-escalation clinical trial.","volume":"164","author":"Y Chang","year":"2014","journal-title":"J Pediatr."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"209-213.e2","DOI":"10.1016\/j.jpeds.2019.02.029","article-title":"Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants.","volume":"210","author":"S Powell","year":"2019","journal-title":"J Pediatr."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"628-35","DOI":"10.1002\/sctm.18-0079","article-title":"First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study.","volume":"7","author":"R Lim","year":"2018","journal-title":"Stem Cells Transl Med."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"291-310","DOI":"10.1016\/j.clp.2019.02.011","article-title":"Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.","volume":"46","author":"E Mandell","year":"2019","journal-title":"Clin Perinatol."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"56-65.e8","DOI":"10.1016\/j.jpeds.2018.10.033","article-title":"rhIGF-1\/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial.","volume":"206","author":"D Ley","year":"2019","journal-title":"J Pediatr."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"15-21.e1","DOI":"10.1016\/j.jpeds.2017.08.006","article-title":"Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development.","volume":"191","author":"R Steinhorn","year":"2017","journal-title":"J Pediatr."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-703\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-703\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-703\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T02:30:11Z","timestamp":1594866611000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-703\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":72,"URL":"https:\/\/doi.org\/10.12688\/f1000research.25338.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.27962.r67070","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.27962.r67069","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-703\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.27962.r67070, Cynthia T. McEvoy, Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, USA, 14 Jul 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-703\/v1#referee-response-67070","order":0,"name":"referee-response-67070","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.27962.r67069, Juan Sanchez-Esteban, Department of Pediatrics, Alpert Medical School of Brown University, Rhode Island, USA, 14 Jul 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-703\/v1#referee-response-67069","order":1,"name":"referee-response-67069","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}